AU Patent

AU2009223649A1 — Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection

Assigned to Novartis AG · Expires 2009-09-17 · 17y expired

What this patent protects

Patent listed against triamcinolone-acetonide.

Drugs covered by this patent

triamcinolone-acetonide (TRIAMCINOLONE ACETONIDE)

Patent Metadata

Patent number: AU2009223649A1
Jurisdiction: AU
Classification: —
Expires: 2009-09-17
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.